- Home
- CNOBP vs BRTX Comparison
CNOBP vs BRTX Comparison
Compare CNOBP & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOBP
- BRTX
- Stock Information
- Founded
- CNOBP N/A
- BRTX 1997
- Country
- CNOBP United States
- BRTX United States
- Employees
- CNOBP 493
- BRTX N/A
- Industry
- CNOBP Major Banks
- BRTX Managed Health Care
- Sector
- CNOBP Finance
- BRTX Health Care
- Exchange
- CNOBP Nasdaq
- BRTX Nasdaq
- Market Cap
- CNOBP N/A
- BRTX 12.6M
- IPO Year
- CNOBP N/A
- BRTX N/A
- Fundamental
- Price
- CNOBP $23.09
- BRTX $1.60
- Analyst Decision
- CNOBP
- BRTX Strong Buy
- Analyst Count
- CNOBP 0
- BRTX 1
- Target Price
- CNOBP N/A
- BRTX $18.00
- AVG Volume (30 Days)
- CNOBP N/A
- BRTX 151.8K
- Earning Date
- CNOBP N/A
- BRTX 08-12-2025
- Dividend Yield
- CNOBP N/A
- BRTX N/A
- EPS Growth
- CNOBP N/A
- BRTX N/A
- EPS
- CNOBP N/A
- BRTX N/A
- Revenue
- CNOBP N/A
- BRTX $391,000.00
- Revenue This Year
- CNOBP N/A
- BRTX $391.52
- Revenue Next Year
- CNOBP N/A
- BRTX $3.50
- P/E Ratio
- CNOBP N/A
- BRTX N/A
- Revenue Growth
- CNOBP N/A
- BRTX 161.54
- 52 Week Low
- CNOBP N/A
- BRTX $1.21
- 52 Week High
- CNOBP N/A
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- CNOBP 57.87
- BRTX 45.93
- Support Level
- CNOBP $22.86
- BRTX $1.51
- Resistance Level
- CNOBP $23.08
- BRTX $1.79
- Average True Range (ATR)
- CNOBP 0.12
- BRTX 0.10
- MACD
- CNOBP 0.00
- BRTX -0.00
- Stochastic Oscillator
- CNOBP 87.76
- BRTX 32.14
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.